<i>Acinetobacter baumannii</i> Infections in Times of COVID-19 Pandemic
The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients. <i>Acinetobacter baumannii</i> frequently causes nosocomial infections, particularly in intensive care units (ICUs), where the incidence has increased over time. Since the WHO declared the COVID-...
Main Authors: | Karyne Rangel, Thiago Pavoni Gomes Chagas, Salvatore Giovanni De-Simone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/8/1006 |
Similar Items
-
An Update on the Therapeutic Potential of Antimicrobial Peptides against <i>Acinetobacter baumannii</i> Infections
by: Karyne Rangel, et al.
Published: (2023-09-01) -
Current State of Antimicrobial Treatment of Lower Respiratory Tract Infections Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Marco Merli, et al.
Published: (2023-05-01) -
Pan-Drug Resistant <i>Acinetobacter baumannii</i>, but Not Other Strains, Are Resistant to the Bee Venom Peptide Melittin
by: Karyne Rangel, et al.
Published: (2020-04-01) -
Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022-09-01) -
<i>Acinetobacter baumannii</i> Bloodstream Infections: A Nationwide Study in Israel
by: Amir Nutman, et al.
Published: (2023-08-01)